tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Rick Bienkowski, 5 are a HOLD (14.29%), 30 are a BUY (85.71%).
Analyst Rick Bienkowski, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 7.22% that have a potential upside of 8.09% achieved within 21 days.
Rick Bienkowski’s has documented 67 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LEGN, Legend Biotech Corp at 14-May-2025.
Analyst best performing recommendations are on VERV (VERVE THERAPEUTICS).
The best stock recommendation documented was for VERV (VERVE THERAPEUTICS) at 2/1/2023. The price target of $21 was fulfilled within 8 days with a profit of $1.07 (4.85%) receiving and performance score of 6.06.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 07-Jan-2026
$28
$0.45 (1.63%)
$41
3 days ago
(07-Jan-2026)
4/5 (80%)
$-0.93 (-3.21%)
133
Hold
Since 10-Aug-2022
$21
$-6.55 (-23.77%)
$25
5 months 4 days ago
(06-Aug-2025)
11/11 (100%)
$2.7 (14.75%)
145
Buy
Since 05-Jan-2022
$55
$27.45 (99.64%)
$78
8 months 3 days ago
(07-May-2025)
0/4 (0%)
$38.77 (238.88%)
Buy
Since 16-Feb-2021
$70
$42.45 (154.08%)
$105
8 months 3 days ago
(07-May-2025)
0/3 (0%)
$53.77 (331.30%)
Since 20-Dec-2022
$40
$12.45 (45.19%)
$57
8 months 18 days ago
(23-Apr-2025)
2/5 (40%)
$20.13 (101.31%)
4
What Year was the first public recommendation made by Rick Bienkowski?
